
- BioPharm International-06-15-2016
- Volume 2016 ebook
- Issue 1
Contract Service Providers Gear Up to Develop Emerging Therapies
Technology advances enable contract service providers to keep pace with the demands of existing and emerging biologic-based therapies.
Technology advances enable contract service providers to keep pace with the demands of existing and emerging biologic-based therapies.
The panelists in this roundtable discussion included: John Allinson, head of biomarker strategy, drug development services at LGC; Martha S. Rook, head of novel therapies, process solutions, MilliporeSigma; Joe Codamo, general manager, Patheon; Brian Hampson, Vice-President, Global Manufacturing Sciences and Technology, PCT, a Caladrius Company; Stephen Gacheru, Executive Director–Biopharmaceutical Product Development, PPD Laboratories; Bruce Stauffer, Executive Director–Immunochemistry Department, PPD Laboratories; and Mark Rogers, VP USA–Life Science, SGS.
Download the
.
Articles in this issue
over 9 years ago
Biopharma Service Providers Address a Full Plate of Challengesover 9 years ago
Dealing with Pharmaceutical Supply-Chain Complexitiesover 9 years ago
Keeping it Simple: Collaborating for Success in Drug Deliveryover 9 years ago
Biomanufacturers Demand Higher Quality Standards in 2016over 9 years ago
Preventing Phase III Failuresover 9 years ago
Outsourcing Industry Marked by Considerable Investments in 2016Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.